Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

Andreas du Bois · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +17

Clinical Features of Hypersensitivity Reactions to Carboplatin

Maurie Markman, Alexander Kennedy, Kenneth Webster et al. · Journal of Clinical Oncology · 1999 · 374 citations

Medicine, Oncology, Pharmacology +17

Histamine and tryptase levels in patients with acute allergic reactions: An emergency department–based study

Robert Y. Lin, Lawrence B. Schwartz, Arlene Curry et al. · Journal of Allergy and Clinical Immunology · 2000 · 277 citations · Full text

Life Sciences, Emergency Medicine, Immunology +13

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions

Chyh-Woei Lee, Ursula A. Matulonis, Mariana Castells · Gynecologic Oncology · 2004 · 162 citations

Medicine, Oncology, Pharmacology +17